Stocks and Investing Stocks and Investing
Wed, June 9, 2021
Tue, June 8, 2021
Mon, June 7, 2021
Fri, June 4, 2021
Thu, June 3, 2021

Matthew Harrison Maintained (AVIR) at Buy with Decreased Target to $35 on, Jun 3rd, 2021


Published on 2024-10-27 16:53:31 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Buy with Decreased Target from $82 to $35 on, Jun 3rd, 2021.

Matthew, nor any peers, have made any analyst calls on AVIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30